Leila Alland
Director/Board Member at ABEONA THERAPEUTICS INC.
Net worth: 342 818 $ as of 2024-04-29
Leila Alland active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. | Director/Board Member | 2021-04-18 | - |
| Independent Dir/Board Member | 2021-04-18 | - | |
| RADIOPHARM THERANOSTICS LIMITED | Director/Board Member | 2022-06-05 | - |
Jubilant Therapeutics, Inc.
 Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ. | Director/Board Member | 2021-08-15 | - |
Career history of Leila Alland
Former positions of Leila Alland
| Companies | Position | Start | End |
|---|---|---|---|
| AFFIMED N.V. | Chief Tech/Sci/R&D Officer | 2018-03-25 | 2019-11-29 |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Chief Tech/Sci/R&D Officer | 2015-12-31 | 2018-02-28 |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Corporate Officer/Principal | 2013-09-30 | 2015-11-30 |
| Albert Einstein College of Medicine, Inc. | Corporate Officer/Principal | 1994-08-31 | 2000-05-31 |
| PMV PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2019-11-30 | - |
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Director/Board Member | 2020-06-23 | - |
Training of Leila Alland
| New York University School of Medicine | Doctorate Degree |
| University of Pennsylvania | Undergraduate Degree |
Statistics
International
| United States | 10 |
| Germany | 2 |
| Australia | 2 |
Operational
| Director/Board Member | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| AFFIMED N.V. | Health Technology |
| PMV PHARMACEUTICALS, INC. | Commercial Services |
| ABEONA THERAPEUTICS INC. | Health Technology |
| RADIOPHARM THERANOSTICS LIMITED | Health Services |
| Private companies | 4 |
|---|---|
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Health Technology |
Jubilant Therapeutics, Inc.
Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ. | Health Technology |
- Stock Market
- Insiders
- Leila Alland
- Experience